LII — Lennox International Inc.

The market's read is straightforward. Q2 2026 (filed 2026-07-29) delivered $1.545B of revenue and flat $7.72 diluted EPS, with management narrowing FY2026 EPS guidance to $23.00-$24.00 from $23.50-$25.00 on slower residential recovery and a top-line consensus miss; Morgan Stanley then cut its price target to $375 with an Underweight rating on 2026-09-03. Sell-side is anchored on Hold (10 buy / 16 hold / 4 sell), the consensus target of $540 is stale versus the $463.67 recent average and the $375 low, and the tape confirms it: as of 2026-09-13 LII was -6.27% in a week, -13.04% in a month, and -28.53% in three, sitting at the bottom of a $365.70-$587.27 52-week range with RSI at 28.64. Nobody is debating whether residential HVAC is soft; they are debating how long.

The revenue line decelerated hard and then inflected: YoY growth ran +9.6% (Q3 2024), +16.5% (Q4 2024), +2.4% (Q1 2025), +3.4% (Q2 2025), then went negative at -4.8% (Q3 2025) and -11.2% (Q4 2025), before flipping back positive at +5.8% (Q1 2026) and +3.0% (Q2 2026, $1.545B). That is a full down-cycle-and-turn, not a one-quarter blip, and the trough in reported revenue was H2 2025. Margins have been remarkably durable through it: Q2 2026 gross margin was 34.9% vs 34.8% a year earlier and operating margin 23.0% vs 23.6%, with operating income essentially flat at $355.0M vs $354.0M on +3.0% revenue. Diluted EPS of $7.72 was flat versus $7.82, and TTM EPS of $22.32 is down about 4.6% from ~$23.39 a year earlier, so this is a mild earnings dip, not a collapse. The cash line is actually improving: TTM free cash flow as of 2026-06-30 was $738.7M versus $680.1M a year earlier (+8.6%), and Q2 2026 alone produced $136.3M. Net read: a high-margin, cash-generative franchise going through a shallow, residential-led cyclical earnings trough while the commercial/rooftop side holds the margin line. One data caveat the deterministic score itself flags: stockholders' equity jumped from $754.0M (2024-09-30) to $850.2M (2024-12-31), and the prior-year comparable quarter was +79%, so any trend comparison spanning that point may be distorted by capital-structure actions rather than operations.

Cheap versus its own history, and cheap for a reason. As of 2026-09-13, LII trades at 16.5x TTM EPS of $22.32 and roughly 15.5x the $23.61 next-FY consensus EPS, against a 5-year average P/E of 23.75x and a 5-year average P/S of 3.04x versus 2.39x today. TTM FCF of $738.7M against a $12.65B market cap is a 5.8% free-cash-flow yield, and EV/EBITDA is 12.95x, both undemanding for a business with 25.5% ROIC and a 19.4% TTM operating margin. The negative PEG of -2.917 is meaningless here because it is being computed off negative trailing growth, not because the stock is expensive. The one ratio that looks alarming, P/B of 9.79, is a decades-of-buybacks artifact (equity of just $1.297B against $12.65B of market cap), not a leverage signal. The discount is real; it is the market repricing a housing-levered compounder down to a slower-growth industrial multiple.

The stock is down roughly 35% from its 52-week high while TTM EPS is down only about 5% - this is multiple compression, not an earnings collapse, and that distinction is the entire trade. The guidance math is the tell: FY2026 guidance of $23.00-$24.00 (midpoint $23.50) sits on H1 2026 EPS of $11.07, which implies H2 2026 EPS of roughly $11.93-$12.93, or +8% to +17% YoY against a weak $11.03 H2 2025 base (Q4 2025 EPS fell to $4.07 from $5.52). So management is explicitly underwritting a second-half recovery, helped by an easy comp and about 5 points of M&A revenue contribution. If the Q3 print shows that step-up materializing, LII is being priced for a downturn it is not actually having at 15.5x forward. If replacement demand stays frozen, expect another cut and a de-rating toward 13-14x on a lower number - which is roughly the Morgan Stanley $375 scenario.

Oversold inside an unbroken downtrend - a bounce setup, not a reversal signal. As of 2026-09-13, RSI(14) stood at 28.64, price was -6.79% versus the 20-day (implied ~$393), -19.97% versus the 50-day (~$457), and -26.28% versus the 200-day (~$497), after -23.89% over six months and -28.53% over three. Every moving average is above price and falling, so the path of least resistance is still down; a 28.6 RSI in that context is a timing bet, not a value bet. Practically, a reclaim of the 20-day near $393 would be the first evidence of stabilization, and the 50-day near $457 only becomes relevant if the fundamental picture turns first - which means the technicals should be used to time an entry after the Q3 print, not as the reason to buy ahead of it.

• Restrictive interest rates: elevated mortgage and home-equity financing costs are pushing homeowners toward patch-and-repair instead of full system replacement, directly suppressing discretionary Home Comfort Solutions volume.
• Residential housing and remodeling softness: deferred replacement demand is accumulating but not converting, and it is the single biggest swing factor in both LII's revenue and its earnings guidance.
• Commercial and data-center cooling demand: Building Climate Solutions is a genuine offset through institutional projects, retrofits and data-center cooling, which is the main reason operating margins have held near 23% despite the residential slump.
• SEER2 efficiency standards and low-GWP refrigerant mandates: multi-year regulatory changes structurally favor scale manufacturers with the engineering and compliance capacity, supporting price/mix and disadvantaging smaller legacy competitors.
• Cyclical industrial and housing-linked sector rotation: capital has rotated away from rate-sensitive industrials, and with a beta of 1.184 and the stock at a 52-week low, LII remains a sentiment hostage until rate expectations and housing data turn.

• Q3 2026 earnings (typically late October/early November 2026): the decisive datapoint - does the implied H2 EPS step-up of +8% to +17% YoY show up, and is residential destocking bottomed?
• M&A contribution and margin realization: FY2026 revenue growth of roughly 8% includes about 5 points from acquisitions (Comfort-Aire, Century, the Ariston joint venture); proving margin capture, not just revenue, would support a re-rating.
• Monetary easing: broader rate cuts would lower consumer financing costs and start unlocking deferred HVAC replacement demand, the cleanest bullish catalyst available.
• Analyst sentiment washout: with 4 sell ratings and a fresh cut to $375, expectations are close to capitulated - a beat-and-raise would force a lot of Hold ratings to move.

• Residential recovery slipping into 2027: FY2026 guidance embeds a second-half EPS acceleration of +8% to +17% YoY that depends entirely on a cycle turn not yet visible in orders.
• No valuation floor if the cycle extends: at 16.5x TTM earnings that are themselves declining, a further cut to FY2026 numbers plausibly puts the stock at 13-14x on a lower base, which is the path to the $375 low target.
• Thin equity from buybacks: stockholders' equity of $1.297B versus $1.149B of long-term debt and only $51.5M of cash (D/E 1.561, LT debt/equity 0.886); net debt/EBITDA of roughly 1.0x is manageable, but the equity base provides little shock absorption if the downturn runs long.
• Price/mix normalization: several years of regulation-driven price increases have flattered the margin line, and 23% operating margins are not a floor if pricing power fades into soft demand.
• Dependence on the commercial data-center offset: if that end market cools while residential stays weak, LII loses the buffer that has kept margins near record levels.

LII is a genuinely high-quality franchise - 25.5% ROIC, 23.0% Q2 2026 operating margin, a 5.8% free-cash-flow yield, and TTM FCF up 8.6% YoY - trading at 15.5x forward earnings against a 5-year average of 23.75x, with the residential cycle rather than the company doing the damage. That is a legitimate value setup for a patient investor, but it is not a clean entry today: the stock is at a 52-week low in an unbroken downtrend (-26% versus the 200-day), guidance quietly requires a strong H2 recovery, and there is no hard evidence yet that replacement demand has bottomed. The risk/reward improves materially on the Q3 print - buy stabilization, not the falling knife.

Forward P/E on trough-cycle consensus earnings, triangulated three ways. Primary: 19x next-FY consensus EPS of $23.61 = $449, where 19x sits between today's 15.5x and the 5-year average of 23.75x and reflects a high-ROIC, margin-resilient industrial in a cyclical lull rather than a broken one. Cross-check one: 15.5x TTM EBITDA of about $1.06B, less $1.098B of net debt, divided by ~34.56M shares = ~$444. Cross-check two: a 4.8% FCF yield on $738.7M of TTM free cash flow = ~$445. All three converge near $445-449, so I use $448 as the single figure - about 22% above the 2026-09-13 price of $366.04, and well below the stale $540 consensus target.